The Association of Serum Osteocalcin with the Bone Mineral Density in Post Menopausal Women
Author:
Open Access
- 1 January 2013
- journal article
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 7 (5) , 814-6
Abstract
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.Keywords
This publication has 9 references indexed in Scilit:
- BMD and Serum Intact Osteocalcin in Postmenopausal Osteoporosis WomenIndian Journal of Clinical Biochemistry, 2010
- Bone turnover markers: understanding their value in clinical trials and clinical practiceOsteoporosis International, 2009
- Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.2007
- Bone Quality — The Material and Structural Basis of Bone Strength and FragilityNew England Journal of Medicine, 2006
- Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) StudyOsteoporosis International, 2004
- Preventing male osteoporosis: prevalence, risks, diagnosis and imaging testsUrologic Clinics of North America, 2004
- Biochemical markers in menopausal women.1997
- High bone turnover is associated with low bone mass in both pre- and postmenopausal womenBone, 1996
- Bone density at various sites for prediction of hip fracturesThe Lancet, 1993